Development of a structurally distinct TopBP1 inhibitor that enhances PARP blockade and reverses osimertinib resistance. (science.org)

Authors: Lin FT … Lin WC Journal: Science Advances Published: 2026-08-05 DOI: https://doi.org/10.1126/sciadv.aeg1996